142 related articles for article (PubMed ID: 2460952)
1. [Randomized double-blind study using mepartricin and a placebo in the therapy of benign prostatic hypertrophy].
Miano L; Manieri C; Paradiso Galatioto G
Minerva Urol Nefrol; 1988; 40(2 Suppl):50-2. PubMed ID: 2460952
[No Abstract] [Full Text] [Related]
2. [Clinical evaluation of the use of mepartricin in the therapy of prostatic hypertrophy. Double-blind study].
Cortecchia V; Scarano P; D'Amato G; Soli M; Rusconi R; Buli P
Minerva Urol Nefrol; 1988; 40(2 Suppl):44-6. PubMed ID: 2460949
[No Abstract] [Full Text] [Related]
3. [Treatment of benign prostatic hypertrophy using mepartricin at high dosage].
Giurioli A; Rosi P; Parziani S; Cesaroni M; Ghamari MR
Minerva Urol Nefrol; 1988; 40(2 Suppl):38-9. PubMed ID: 2460947
[No Abstract] [Full Text] [Related]
4. [Prolonged medical therapy using mepartricin in prostatic hypertrophy. Results in 81 patients].
Serretta V; Pavone C; Di Trapani D; Romano C; Costa G; Caramia G
Minerva Urol Nefrol; 1988; 40(2 Suppl):55-8. PubMed ID: 2460954
[No Abstract] [Full Text] [Related]
5. [Use of mepartricin in the treatment of benign prostatic hypertrophy. Open study of 39 patients].
Montanari E; Patelli E; Mandressi A; Magri V; Pisani E
Minerva Urol Nefrol; 1988; 40(2 Suppl):25-9. PubMed ID: 2460942
[No Abstract] [Full Text] [Related]
6. [Use of mepartricin in the patient suffering from so-called benign prostatic hypertrophy. Study of 142 cases].
Fiorilla C
Minerva Urol Nefrol; 1988; 40(2 Suppl):35-7. PubMed ID: 2460946
[No Abstract] [Full Text] [Related]
7. [Clinical experience with mepartricin in the treatment of prostatic hypertrophy. Preliminary results].
Bassi P; Oliva G; Tasca A; Aragona F; Milani C; Zattoni F
Minerva Urol Nefrol; 1988; 40(2 Suppl):40-3. PubMed ID: 2460948
[No Abstract] [Full Text] [Related]
8. [Mepartricin versus placebo in the therapy of prostatic hypertrophy].
Fini M; Perrone A; Ferraresi R; Salvi G; Misuriello G; Vagliani GF
Minerva Urol Nefrol; 1988; 40(2 Suppl):53-4. PubMed ID: 2460953
[No Abstract] [Full Text] [Related]
9. [Clinical and echographic evaluation of a group of 40 patients suffering from benign prostatic hypertrophy treated with mepartricin].
Alei G
Minerva Urol Nefrol; 1988; 40(2 Suppl):59-61. PubMed ID: 2460955
[No Abstract] [Full Text] [Related]
10. [Evaluation of the objective efficacy of mepartricin in benign prostatic hypertrophy].
Cirillo Marucco E; Giocoli Nacci G; Pagliarulo A; Balacco G; Ludovico G
Minerva Urol Nefrol; 1988; 40(2 Suppl):23-4. PubMed ID: 2460941
[No Abstract] [Full Text] [Related]
11. [Urination disorders, endocrine features and sexual activity in patients with benign prostatic hypertrophy under treatment with mepartricin].
Scarpa RM; Migliari R; De Lisa A; Campus G; Usai E
Minerva Urol Nefrol; 1988; 40(2 Suppl):18-20. PubMed ID: 2460939
[No Abstract] [Full Text] [Related]
12. [Evaluation of the results and tolerance of prolonged treatment with mepartricin].
Bianchi G; Curti P; De Iorio M; Mobilio G
Minerva Urol Nefrol; 1988; 40(2 Suppl):33-4. PubMed ID: 2460945
[No Abstract] [Full Text] [Related]
13. [Double-blind study on the effects of mepartricin (SPA-S-160) versus placebo in the treatment of obstruction caused by adenoma of the prostate].
Rizzo M; Tosto A; Dattolo E; Serni S
Minerva Urol Nefrol; 1988; 40(2 Suppl):21-2. PubMed ID: 2460940
[No Abstract] [Full Text] [Related]
14. [Role of mepartricin in patients with benign prostatic hypertrophy. Study of 24 patients].
Fiorilla C; Mosele G
Minerva Urol Nefrol; 1987; 39(4):369-72. PubMed ID: 2453930
[No Abstract] [Full Text] [Related]
15. [Clinical evaluation of mepartricin in benign prostatic hypertrophy].
Giannotti P; Murzi P; Marconi A; Pistolesi D; Morelli G
Minerva Urol Nefrol; 1988; 40(3):175-80. PubMed ID: 2467388
[No Abstract] [Full Text] [Related]
16. [Latest contribution concerning the use of mepartricin in adenoma of the prostate].
Comar OB; Di Rienzo A
Minerva Urol Nefrol; 1988; 40(2 Suppl):30-2. PubMed ID: 2460944
[No Abstract] [Full Text] [Related]
17. [Medical treatment of benign prostatic hypertrophy. Echographic evaluation].
Traficante A; Martino P; Battaglia M
Minerva Urol Nefrol; 1988; 40(2 Suppl):47-9. PubMed ID: 2460950
[No Abstract] [Full Text] [Related]
18. [Use of mepartricin in the treatment of benign prostatic hypertrophy. Evaluation of clinical and functional parameters].
Petrone U; Gaspari G; Magnocavallo N; Petrone D; Tucci C; Marascia G
Minerva Urol Nefrol; 1988; 40(2):89-91. PubMed ID: 2459785
[No Abstract] [Full Text] [Related]
19. [Evaluation of the pharmacological effect of mepartricin in urological pathology by prostatic superficial echotomography].
Gasparini-Casari M; Palmieri B; Noera G; Ferrari P
Minerva Urol; 1980; 32(1):5-10. PubMed ID: 6155599
[No Abstract] [Full Text] [Related]
20. [Mepartricin in prostatic hypertrophy. Results in 20 cases].
Durval A; Rovereto B; Tosto A; Paoletti MC; Natali A; Pellegrini GL
Minerva Urol Nefrol; 1986; 38(1):81-5. PubMed ID: 2426804
[No Abstract] [Full Text] [Related]
[Next] [New Search]
